These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16829119)

  • 1. Novel targets in gastric and esophageal cancer.
    Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies in the treatment of gastric cancer.
    Ngeow J; Tan IB; Choo SP
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel targeted therapies in the treatment of gastric and esophageal cancer.
    Tabernero J; Macarulla T; Ramos FJ; Baselga J
    Ann Oncol; 2005 Nov; 16(11):1740-8. PubMed ID: 15980157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy for oesophageal cancer: an overview.
    Syrigos KN; Zalonis A; Kotteas E; Saif MW
    Cancer Metastasis Rev; 2008 Jun; 27(2):273-88. PubMed ID: 18224295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
    Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer.
    Sutter AP; Zeitz M; Scherübl H
    Onkologie; 2004 Feb; 27(1):17-21. PubMed ID: 15007244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted agents and esophageal cancer--the next step?
    Aklilu M; Ilson DH
    Semin Radiat Oncol; 2007 Jan; 17(1):62-9. PubMed ID: 17185199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.
    Lee W; Patel JH; Lockhart AC
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1351-64. PubMed ID: 19642951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies for esophageal cancer.
    Tew WP; Kelsen DP; Ilson DH
    Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key cancer cell signal transduction pathways as therapeutic targets.
    Bianco R; Melisi D; Ciardiello F; Tortora G
    Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagogastric cancer: targeted agents.
    Ku GY; Ilson DH
    Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular therapy targets in lung cancer].
    Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
    Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer.
    Ayyappan S; Prabhakar D; Sharma N
    Anticancer Res; 2013 Oct; 33(10):4139-55. PubMed ID: 24122977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets for anticancer treatment development in colorectal cancer.
    Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
    Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal cancer: current and emerging therapy modalities.
    Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of growth factor receptors in esophageal cancer--implications for therapy.
    Ekman S; Bergqvist M; Heldin CH; Lennartsson J
    Oncologist; 2007 Oct; 12(10):1165-77. PubMed ID: 17962610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging drugs for esophageal cancer.
    Homs MY; Voest EE; Siersema PD
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):329-39. PubMed ID: 19453287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.